Rgls stock price target

Current, Vs Industry, Vs History. 3-Year Average Share Buyback Ratio, -57.6. Valuation & Return. Current, Vs Industry, Vs History. Price-to-Tangible-Book, 0.48 . RGLS Stock Price, Forecast & News (Regulus Therapeutics)

3 Wall Street analysts have issued twelve-month price objectives for Regulus Therapeutics' shares. Their forecasts range from $1.00 to $2.00. On average, they  Find the latest analyst research for Regulus Therapeutics Inc. Common Stock ( RGLS) at Nasdaq.com. See Regulus price target based on 3 analysts offering 12 month price targets for Regulus in the last 3 months. The average price target is $1.50 with a high  RGLS | Complete Regulus Therapeutics Inc. stock news by MarketWatch. Regulus Therapeutics stock price target cut to 35 cents from $2.00 at Leerink. Jul. Regulus Therapeutics Stock Price Forecast, RGLS stock price prediction. The best long-term & short-term Regulus Therapeutics share price prognosis for 2020 ,  Regulus Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. RGLS updated stock price target summary. Find the latest Regulus Therapeutics Inc. (RGLS) stock quote, history, news and Analysts Are Upgrading Regulus Therapeutics Inc. After Its Latest Results.

Regulus Therapeutics Stock Quote. RGLS - Stock Price, News ...

Mar 12, 2020 Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs to treat a  by multiplying the current stock price by the number of shares outstanding. and developing drugs that target microRNAs, called microRNA therapeutics. Get detailed information on REGULUS THERAPEUTICS INC (RGLS.NQ) including stock quotes, financial news, historical charts, company background,  Regulus Therapeutics Inc. (RGLS) flow (DCF) valuation over 15 years showing the resulting Target Share Price. Preferred Stock and Other Adjustments. Real time Regulus Therapeutics (RGLS) stock price quote, stock graph, news & analysis. Insider Trading Alert - DUK, STFC And RGLS Traded By Insiders. MARKETS Webster Financial (WBS) Stock Closed Down, Barclays Lowered Price Target. Learn about RGLS with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on RGLS. Stock Style. Large-Cap Value 

Regulus Therapeutics Inc. (RGLS) Stock Message Board ...

Regulus Therapeutics Inc. - RGLS - Stock Price Today - Zacks View Regulus Therapeutics Inc. RGLS investment & stock information. Get the latest Regulus Therapeutics Inc. RGLS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. RGLS Stock Price and Chart — NASDAQ:RGLS — TradingView View live REGULUS THERAPEUTICS INC chart to track its stock's price action. Find market predictions, RGLS financials and market news. View live REGULUS THERAPEUTICS INC chart to track its stock's price action. Find market predictions, RGLS financials and market news. Speculative entry at current price Exit Target Criteria- Momentum Stop Regulus Therapeutics Inc. (RGLS) Interactive Stock Chart ... Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today

Regulus Therapeutics’ (RGLS) Hold Rating Reaffirmed at ...

Regulus Therapeutics Inc (NASDAQ:RGLS) Receives $1.31 ... One analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $1.31. RGLS has been the subject of …

RGLS | Regulus Therapeutics Inc. Analyst Estimates ...

Apr 02, 2020 · regulus therapeutics inc (rgls): * regulus therapeutics (rgls) - on march 24, co received letter from nasdaq - sec filing. * regulus therapeutics (rgls) - letter advised co that for 30 consecutive trading days preceding date of notice, bid price of co s common stock had closed below minimum bid price requirement source : further company coverage: Regulus Therapeutics Inc Stock Quote: RGLS Stock News ... Nov 05, 2019 · RGLS, Regulus Therapeutics Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines

Online Stock Comparison - Compare Regulus Therapeutics Inc. (RGLS) to four other stocks with NASDAQ.com's stock comparison tool. RGLS - Regulus Therapeutics Stock Price - Barchart.com 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share.